CD79A and lymphopenia: We further confirmed that 10 μg of E. coli LPS also increased OVA-specific IgA production in the nasal wash (Supplementary Figure 1); however, mice receiving LPS from E. coli, but not Alcaligenes, showed severe side effects, such as lymphopenia (Supplementary Figure 2), which is consistent with our previous study (6).